Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Common drug tested to stop dangerous heartbeat after surgery

NCT ID NCT07287345

Summary

This study is testing if a common anti-inflammatory drug called colchicine can prevent a dangerous irregular heartbeat after heart bypass surgery. About 24 adults having planned bypass surgery will be randomly assigned to receive either colchicine or a placebo pill for a short time after their operation. Researchers will measure inflammation in the blood and track who develops the irregular heartbeat to see if the drug helps.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COLCHICINE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of Kentucy

    RECRUITING

    Lexington, Kentucky, 40536, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.